Utility of Hull airway reflux questionnaire for the evaluation of clinical features of severe asthma

Utility of Hull airway reflux questionnaire for the evaluation of clinical features of severe asthma - Utility of HARQ for the evaluation of severe asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040732

Enrollment

300

Registered

2020-06-12

Start date

2020-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with asthma who completed the Hull airway reflux questionnaire who visited our department of respiratory Medicine for asthma between August 2018 and July 2020.

Exclusion criteria

Exclusion criteria: (1) Smoking history of 10 pack-years, or complications of chronic obstructive pulmonary disease. (2) Patients with other respiratory diseases that are clearly affected their respiratory status, (3) Minors (4) Patients who are judged to be unsuitable as subjects by researchers.

Design outcomes

Primary

Measure	Time frame
We will evaluate associations of Hull airway reflux questionnaire with 4 clinical features of severe asthma made by the ERS/ATS guideline.	—

Countries

Japan

Contacts

Public ContactRyota Kurokawa

Nagoya City University Graduate School of Medical Sciences Department of Respiratory Medicine, Allergy and Clinical Immunology

rkforresearch@gmail.com052-853-8216

Outcome results